First pharmaceutical company in Fortune Magazine’s World’s Most Admired Companies list

For the second consecutive year, Fortune Magazine ranked Johnson & Johnson, the parent company of Janssen as the number one in the Pharmaceuticals category on its annual World’s Most Admired Companies list. Johnson & Johnson also ranked as number 11 in the overall rankings for 2015. Janssen (Johnson & Johnson) achieved the #1 pharmaceutical industry ranking in 6 out of 9 key reputation attributes:

  • People Management
  • Use of Corporate Assets
  • Social Responsibility
  • Quality of Management
  • Financial Soundness
  • Long Term Investment Value
Further, Janssen (Johnson & Johnson) maintained or improved our pharmaceutical industry ranking..

More News

28 February is Rare Disease Day

Over 6000 different rare diseases have been identified to date, directly affecting the daily life of more than 30 million people in Europe alone. The complex nature of rare diseases, coupled with limited access to treatment and services, means that..

Janssen goes deep for geothermal energy in Belgium

The Janssen site in Beerse, Belgium will be drilling deep into hot water layers to utilise geothermal energy to create heat and electricity for its facility and other surrounding companies. Janssen is convinced of the sustainable opportunities presented by the..

Janssen Launches Three New Research Platforms

Raritan, New Jersey, February 12, 2015 – Janssen Research & Development, LLC (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today the launch of three new research platforms focused on disease prevention, disease interception, and the..

Our support for European Medicine Donations

A new initiative, EUROPEAN MEDICINE DONATIONS or EURMED in short, was launched at Clarence House in London in December 2014 by International Health Partners in partnership with Banco Farmaceutico and Action Medeor. The launch coincided with the tenth anniversary of..

Collaborating To Improve Health:
a new Janssen report about partnering in healthcare

 

Browse the full report here

 

extraordinary efforts

a race against time

the world is our lab

transforming the study

we make hope

Quote of the Month - Magdalena Kalata, President of the European Health Parliament.

 

From-Molecule-to-Medicine